Cel-sci

(NYSEMKT) CVM

Current Price$1.13

Market Cap$16.52M

Since IPO (1992)-100%

5 Year-100%

1 Year-55%

1 Month-23%

Cel-sci Financials at a Glance

Market Cap

$16.52M

Revenue (TTM)

$0.00

Net Income (TTM)

-$22.70M

EPS (TTM)

-$3.48

P/E Ratio

-0.33

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$1.13

Volume

658,534

Open

$1.06

Price

$1.13

Volume

658,534

Open

$1.06

Previous Close

$1.14

Daily Range

$1.06 - $1.17

52-Week Range

$0.89 - $13.48

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$1.13

Volume

658,534

Open

$1.06

Previous Close

$1.14

Daily Range

$1.06 - $1.17

52-Week Range

$0.89 - $13.48

Estimated Earnings Date

Aug 17, 2026

CVM News

Why CEL-SCI Stock Soared Today

Keith SpeightsJul 7, 2021

Will All End Well for This Popular Reddit Biotech?

Zhiyuan SunJun 30, 2021

Can You Count on This Popular Reddit Cancer-Treatment Stock?

Zhiyuan SunJun 5, 2021

Here’s What’s Behind The Hottest Battleground Stock in Cancer Treatment

Zhiyuan SunApr 24, 2020

Charts going up with man looking thru skyscraper window

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cel-sci

Industry

Biotechnology

Sector

Health Care

CEO

Geert R. Kersten, MBA

Website

www.cel-sci.com

Headquarters

Vienna, VA 22182, US

CVM Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-221.50%

Return on Capital

-97.90%

Return on Assets

-128.20%

Earnings Yield

-3.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.52M

Shares Outstanding

14.49M

Volume

658.53K

Avg. Volume

465.76K

Financials (TTM)

Gross Profit

-$2.88M

Operating Income

-$22.22M

EBITDA

-$18.35M

Operating Cash Flow

-$16.65M

Capital Expenditure

-$5.15K

Free Cash Flow

-$16.66M

Cash & ST Invst.

$1.89M

Total Debt

$8.51M

Cel-sci Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$956.40K

N/A

Gross Margin

0.00%

N/A

Market Cap

$16.52M

N/A

Market Cap/Employee

$384.23K

N/A

Employees

N/A

Net Income

-$5.47M

+16.8%

EBITDA

-$4.39M

+19.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$1.89M

-1.7%

Total Debt

$8.51M

-19.2%

Accounts Receivable

$0.00

N/A

Inventory

$281.46K

-68.1%

Long Term Debt

$5.90M

-27.9%

Short Term Debt

$2.61M

+11.3%

Return on Assets

-1.28%

N/A

Return on Invested Capital

-1.72%

N/A

Free Cash Flow

-$4.02M

+8.0%

Operating Cash Flow

-$4.02M

+8.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.62-3.26%

TPSTTempest Therapeutics, Inc.

TPSTTempest Therapeutics, Inc.$1.09-1.80%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$5.59+2.57%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

INMBINmune Bio, Inc.

INMBINmune Bio, Inc.$1.70+1.19%

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$0.85-2.39%

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.29+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

NOKNokia

NOKNokia$12.07-0.07%

Questions About CVM

What is the current price of Cel-sci?

Cel-sci is trading at $1.14 per share.

What is the 52-week range for Cel-sci?

Over the past 52 weeks, Cel-sci has traded between $0.89 and $13.48.

How much debt does Cel-sci have?

As of the most recent reporting period, Cel-sci reported total debt of $8.51M.

How much cash does Cel-sci have on hand?

Cel-sci reported $1.89M in cash and cash equivalents in its most recent financial results.

What is Cel-sci’s dividend yield?

Cel-sci does not currently have a dividend yield.

Cel-sci

Cel-sci Financials at a Glance

CVM News

Why CEL-SCI Stock Soared Today

Will All End Well for This Popular Reddit Biotech?

Can You Count on This Popular Reddit Cancer-Treatment Stock?

Here’s What’s Behind The Hottest Battleground Stock in Cancer Treatment

These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?

One Biotech Stock to Avoid

An Inside Look at Biotech Investing, Part 2

CEL-SCI Investors Cheer a Bit Too Loudly

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cel-sci

CVM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cel-sci Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CVM

What is the current price of Cel-sci?

What is the 52-week range for Cel-sci?

How much debt does Cel-sci have?

How much cash does Cel-sci have on hand?

What is Cel-sci’s dividend yield?

Premium Investing Services